H2-M10.6 inhibitors represent a distinct category of chemical compounds that have been designed to regulate the activity of the H2-M10.6 protein. H2-M10.6, also referred to as histocompatibility 2, M region locus 10.6, is a protein found within the major histocompatibility complex (MHC) system, a vital component of the immune system in mice. The MHC's primary function is to present antigenic peptides to T cells, enabling the immune system to identify and respond to foreign pathogens effectively. H2-M10.6, like other MHC molecules, plays a pivotal role in this process of antigen presentation, which is essential for initiating immune responses against infections. The development of H2-M10.6 inhibitors is centered around the objective of selectively interacting with the H2-M10.6 protein, potentially influencing its antigen-presenting activity and impacting immune recognition processes.
H2-M10.6 inhibitors typically comprise small molecules or chemical compounds that are purposefully engineered to bind to H2-M10.6, targeting either its active site or allosteric sites. This interaction has the potential to modify H2-M10.6's behavior, potentially affecting its ability to present antigenic peptides to T cells and, consequently, influencing the immune response against foreign antigens. Researchers are dedicated to unraveling the molecular mechanisms and functions of H2-M10.6 within the MHC system, aiming to gain insights into the complex immune recognition processes. The development of H2-M10.6 inhibitors represents an ongoing area of research within the fields of immunology and molecular pharmacology, contributing to a deeper understanding of the immune system's functioning and its role in detecting and responding to foreign antigens.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Intercalates into DNA, disrupting DNA and RNA synthesis which can lead to inhibited gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds tightly to DNA, inhibiting RNA polymerase and thus blocking RNA synthesis and gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, a critical enzyme in the transcription process, leading to reduced mRNA synthesis and gene expression. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
DNA intercalator and topoisomerase II inhibitor that can disrupt DNA replication and transcription, affecting gene expression. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Inhibits DNA polymerase, leading to S phase arrest and potentially downregulating gene expression. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Terminates RNA chain elongation due to its similarity to adenosine but lack of a 3' hydroxyl group, reducing gene expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase, inhibiting RNA synthesis. In eukaryotes, it could affect mitochondrial gene expression. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Targets DNA gyrase in bacteria and can affect topoisomerases in eukaryotic cells, potentially decreasing gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to DNA and prevents binding of transcription factors, particularly to G-C rich regions, downregulating gene expression. | ||||||